These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10069680)

  • 1. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J; Pribnow DG; Giraud GD; Perkins KD; Muldoon L; Greenberg BH
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats.
    Hanatani A; Yoshiyama M; Takeuchi K; Kim S; Nakayama K; Omura T; Iwao H; Yoshikawa J
    Jpn J Pharmacol; 1998 Sep; 78(1):45-54. PubMed ID: 9804061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy.
    Flesch M; Schiffer F; Zolk O; Pinto Y; Stasch JP; Knorr A; Ettelbrück S; Böhm M
    J Hypertens; 1997 Sep; 15(9):1001-9. PubMed ID: 9321748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.
    Nguyen QT; Colombo F; Clement R; Gosselin H; Rouleau JL; Calderone A
    Br J Pharmacol; 2003 Apr; 138(8):1485-94. PubMed ID: 12721104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valsartan and coronary haemodynamics in early post-myocardial infarction in rats.
    Gervais M; Richer C; Fornes P; De Gasparo M; Giudicelli JF
    Fundam Clin Pharmacol; 1999; 13(6):635-45. PubMed ID: 10626750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.
    Richer C; Fornes P; Cazaubon C; Domergue V; Nisato D; Giudicelli JF
    Cardiovasc Res; 1999 Jan; 41(1):100-8. PubMed ID: 10325957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction.
    Xia QG; Chung O; Spitznagel H; Sandmann S; Illner S; Rossius B; Jähnichen G; Reinecke A; Gohlke P; Unger T
    Eur J Pharmacol; 1999 Dec; 385(2-3):171-9. PubMed ID: 10607873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY; Huang YL; Sun YH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1053-6. PubMed ID: 16029550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix.
    Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Nakayama H; Otsu K; Suzuki K; Tada M; Hori M; Miwa T; Masuyama T
    J Hypertens; 2003 Sep; 21(9):1737-45. PubMed ID: 12923407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction.
    Hongo M; Sentianin EM; Tanaka N; Mao L; McKirnan MD; Clark RG; Won W; Chien KR; Ross J
    J Card Fail; 1998 Sep; 4(3):213-24. PubMed ID: 9754592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
    Jugdutt BI; Menon V
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan.
    Guo X; Chapman D; Dhalla NS
    Mol Cell Biochem; 2003 Dec; 254(1-2):163-72. PubMed ID: 14674695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of differential blockade of the renin-angiotensin system in postinfarcted rats.
    Lacour C; Roccon A; Galindo G; Canals F; Hogie M; Segondy D; Briand D; Roque C; Herbert JM; Nisato D
    Fundam Clin Pharmacol; 2004 Jun; 18(3):299-307. PubMed ID: 15147281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial changes in sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy in the rat: effect of an angiotensin II receptor antagonist.
    Hashida H; Hamada M; Hiwada K
    Clin Sci (Lond); 1999 Apr; 96(4):387-95. PubMed ID: 10087246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.